Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: September 2020

MissionIRNewsBreaks – The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) Featured in Exclusive Broadcast

The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), a producer of premium bottled alkaline and flavored-infused drinking waters and CBD-infused products, today announced that it was featured in a broadcast titled, “New Opportunities Abound for Specialty Beverage, Water Companies.” The … Continue reading

Posted in MissionIRNewsBreaks, The Alkaline Water Company Inc. WTER | Leave a comment

MissionIRNewsBreaks – 180 Life Sciences Corp. Advancing Lead Program, Plans Additional Clinical Trials

180 Life Sciences, a clinical-stage biotechnology company, is dedicated to producing solutions designed to battle inflammation when the body’s natural processes go awry. The company’s primary focus is to treat fibrosis and inflammation using anti-TNF therapy, designed to block the … Continue reading

Posted in 180 Life Sciences Corp., KBL Merger Corp. IV KBLM | Leave a comment

MissionIRNewsBreaks – SRAX Inc.’s (NASDAQ: SRAX) Sequire Provides Key Insight for Public Company Execs

SRAX (NASDAQ: SRAX), a provider of digital-marketing and consumer data-management technology products, gives public companies an edge with critical data to successfully activate media campaigns, engage shareholders and attract investment. The company’s data analytics platform – Sequire – has proven … Continue reading

Posted in SRAX, Inc. SRAX | Leave a comment

MissionIRNewsBreaks – Cybin Corp. Leverages Two-Pronged Approach to Target Psychedelic, Nutraceutical Sectors

Cybin Corp., a Canada-based life-science company, looks to benefit from its growing footprint in two billion-dollar markets: nutraceuticals and psychedelic drugs. Both sectors are projected to see significant growth in the coming years. The global nutraceutical market was valued at … Continue reading

Posted in Cybin Corp. | Leave a comment

MissionIRNewsBreaks – Trxade Group Inc. (NASDAQ: MEDS) Shines Spotlight on Dynamic Platform Capabilities

Trxade Group (NASDAQ: MEDS), an integrated drug-procurement, delivery and health-care platform, recently had the opportunity to showcase its growing medical technology accomplishments at multiple virtual investor conferences. Trxade Group CEO Suren Ajjarapu took the company’s message well beyond physical borders … Continue reading

Posted in Trxade Group Inc. (MEDS) | Leave a comment

CNS Pharmaceuticals Inc. (NASDAQ: CNSP) is “One to Watch”

CNS Pharmaceuticals’ lead drug candidate, Berubicin, is proposed for the treatment of glioblastoma multiforme (“GBM”), an aggressive and currently incurable form of brain cancer. In a Phase I clinical trial of Berubicin in malignant brain tumors, 44% of patients experienced … Continue reading

Posted in CNS Pharmaceuticals Inc. CNSP | Leave a comment

180 Life Sciences Corp. Leading Research into Novel Drug Therapies Expected to Produce First Results of Phase 2b/3 Trial in 2021

Anti-inflammatory therapeutics market to generate revenues of $191.42 billion through 2027 Novel drug therapy for Fibrosis and Anti-TNF trials being conducted by Professor Sir Marc Feldmann, who already developed one of the most commonly used anti-TNF medications, Remicade The number … Continue reading

Posted in 180 Life Sciences Corp., KBL Merger Corp. IV KBLM | Leave a comment

MissionIRNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Announces AGM Results

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, on Thursday announced voting results of its annual general and special meeting of shareholders (“AGM”). According to the update, shareholders voted in favor of each of the … Continue reading

Posted in Canopy Rivers Inc. CNPOF, Canopy Rivers Inc. RIV, MissionIRNewsBreaks | Leave a comment

MissionIRNewsBreaks – The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) Expanding A88CBD(TM) Line with Highly Anticipated Ingestible and Topical Products

The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER), a producer of premium bottled alkaline and flavored-infused drinking waters and CBD-infused products, on Thursday announced that it will introduce new A88CBD(TM) infused ingestible and topical products for its lifestyle brand at … Continue reading

Posted in MissionIRNewsBreaks, The Alkaline Water Company Inc. WTER | Leave a comment

Predictive Oncology Inc.’s (NASDAQ: POAI) Soluble Biotech Inks Major Contract; Skyline Medical Seals STREAMWAY Deal

POAI’s Soluble Biotech announces first substantial contract with pharmaceutical company since acquisition Founder calls contract “major milestone,” validation of move into new facility POAI’s Skyline Medical sells eight proprietary STREAMWAY(R) systems to Virginia-based hospital organization Soluble Biotech, a division of … Continue reading

Posted in Predictive Oncology Inc. POAI | Leave a comment